Related Experiment Videos
Antibiotics in acute bronchitis: a meta-analysis.
S Bent1, S Saint, E Vittinghoff
1Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco Veterans Affairs Medical Center, 94121, USA.
The American Journal of Medicine
|July 14, 1999
Summary
Antibiotics offer minimal benefit for acute bronchitis, reducing cough and sputum duration by about half a day. Given risks and antibiotic resistance, their use is not recommended for otherwise healthy patients.
Area of Science:
- Medical Research
- Infectious Diseases
- Pharmacology
Background:
- Acute bronchitis is commonly treated with antibiotics, despite uncertain efficacy.
- Antibiotic overuse contributes to antimicrobial resistance.
Purpose of the Study:
- To evaluate the effectiveness of antibiotics in treating acute bronchitis through a meta-analysis.
- To determine if antibiotics provide a significant clinical benefit for acute bronchitis symptoms.
Main Methods:
- Meta-analysis of eight randomized controlled trials (RCTs) published from 1966 to 1998.
- Included RCTs focused on otherwise healthy patients diagnosed with acute bronchitis.
- Compared antibiotic treatment (erythromycin, doxycycline, trimethoprim/sulfamethoxazole) versus placebo.
Main Results:
- Antibiotic use resulted in a small reduction in cough and sputum duration (approx. 0.5 days).
- Trends for decreased purulent sputum, cough duration, and days lost from work were not statistically significant.
- Summary effect size for symptom duration was 0.21 (95% CI, 0.05 to 0.36).
Conclusions:
- Antibiotics show a marginal benefit in treating acute bronchitis in healthy individuals.
- The small clinical advantage is outweighed by potential side effects and the societal impact of antibiotic resistance.
- Current evidence does not support the routine use of antibiotics for acute bronchitis in this patient population.